BIM
CRBP icon

BlackRock Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

BlackRock Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$56K Sell
220
-7
-3% -$1.6K ﹤0.01% 3307
2016
Q3 		$46K Buy
227
+33
+17% +$4.11K ﹤0.01% 3299
2016
Q2 		$17K Buy
194
+91
+88% +$7.13K ﹤0.01% 3426
2016
Q1 		$6K Hold
103
– – ﹤0.01% 3765
2015
Q4 		$5K Hold
103
– – ﹤0.01% 3858
2015
Q3 		$5K Hold
103
– – ﹤0.01% 3921
2015
Q2 		$10K Buy
+103
New +$10.4K ﹤0.01% 3718

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BlackRock Investment Management's CRBP Position: Q4 2016 in Review

BlackRock Investment Management reduced its Corbus Pharmaceuticals (CRBP) stake by 3.1% in Q4 2016, selling an estimated $1.6K and leaving 220 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #3307.

BlackRock Investment Management first reported a position in CRBP in Q2 2015 and has held it in 7 quarters since. 49 funds tracked by Wall St. Rank hold CRBP as of Q4 2016.

  • BlackRock Investment Management held 220 shares of Corbus Pharmaceuticals worth $56K as of Q4 2016.
  • BlackRock Investment Management sold 7 Corbus Pharmaceuticals shares in Q4 2016, an estimated $1.6K.
  • Corbus Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3307 holding.
  • BlackRock Investment Management first reported a position in Corbus Pharmaceuticals in Q2 2015 and has held it in 7 quarters since.
  • 49 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.